Alcoholic hepatitis Hospitalist Best Practice J Rush Pierce Jr, MD, MPH Lenny Noronha, MD September 11, 2013.

Slides:



Advertisements
Similar presentations
Best Practice Tom Shiffler, MD 7/23/10
Advertisements

Risё Stribling, MD Medical Director of Liver Transplant St Luke’s Medical Center Associate Professor of Surgery Baylor College of Medicine.
DIABETES AND THE KIDNEYS
Management of Hepatic Encephalopathy in the Hospital
CONSENSUS: Cooperative North Scandinavian Enalapril Survival Study Purpose To determine whether the ACE inhibitor enalapril reduces mortality in patients.
Cirrhosis of the Liver Kayla Shoaf.
LDL Cholesterol Goals and Cutpoints for Therapeutic Lifestyle Changes (TLC) and Drug Therapy in Different Risk Categories Risk Category LDL Goal (mg/dL)
Liver Cirrhosis S. Diana Garcia
BY MELISSA JAKUBOWSKI PULMONARY DISEASE TREATMENT CONCERNING COPD.
Cost-Conscious Care Presentation Follow-up Chest X-Ray in Patients Admitted for Community Acquired Pneumonia Huy Tran, PGY-2 12/12/2013.
I n t e g r i t y - S e r v i c e - E x c e l l e n c e Headquarters U.S. Air Force 1 Clinical Assessment of Alcohol Use.
HSV-Induced Acute Liver Failure: Treat First…..Diagnose Later? HSV-Induced Acute Liver Failure: Treat First…..Diagnose Later? Wiley D. Truss MD, MPH and.
Clinical Therapeutics Naltrexone for the Management of Alcohol Dependence Raymond F. Anton, M.D. N Engl J Med Volume 359(7): August 14, 2008.
HEPATO renal Syndrome Type I: Correct Diagnosis = Correct Management Stephen G. M. Wong BSc, BSc(Med), MD, MHSc, FRCPC Associate Professor of Medicine.
Randomized, double-blind, multicenter, controlled trial.
Sugar control in Critical care unit Senior clinical pharmacist : Lihua Fang Koo Foundation Cancer Center.
Intensive versus Conventional Glucose Control in Critical Ill Patients N Engl J Med 2009; 360: 雙和醫院 劉慧萍藥師.
Patient presenting with altered mental status
Optimizing Nutrition Therapy
INTERFERENCE TO NUTRITIONAL NEEDS DUE TO DEGENERATION AND INFLAMMATION Cirrhosis and Hepatitis.
Gastrointestinal Review Highlights of the VIGOR Trial Lawrence Goldkind M.D.
Using procalcitonin to care for hospitalized patients Hospitalist Best Practice J Rush Pierce Jr, MD, MPH Division of Hospital Medicine July 22, 2015.
1 Kennedy Roberts Senior Medical Officer and Clinical Lead North Cluster Glasgow Addiction Services Community Addiction Teams What are the challenges for.
Alcohol. Plan Role play in small groups Discuss any issues which arise Go through some of the basics Cover the entire “journey”
Oral Rivaroxaban for Symptomatic Venous Thromboembolism.
Case Report and Lit Review: Reduction of Proteinuria in Diabetic Nephropathy with Spironolactone Harry W. Floyd, M.D. Family Medicine Kingstree, South.
Cirrhosis Dr. Meg-angela Christi M. Amores. Cirrhosis a histopathologically defined condition – pathologic features consist of the development of fibrosis.
Spontaneous Bacterial Peritonitis Katherine Yu May 2014.
HOPE: Heart Outcomes Prevention Evaluation study Purpose To evaluate whether the long-acting ACE inhibitor ramipril and/or vitamin E reduce the incidence.
A 57-year-old man presents with fatigue for several months. He underwent a blood transfusion with several units in 1982 after car accident. Physical examination.
Stress Ulcer Prophylaxis in the Intensive Care Unit (SUP-ICU) Screening and randomisation Mette Krag Dept. of Intensive Care 4131 Copenhagen University.
Dr. Ravi kant Assistant Professor Department of General Medicine.
INPULSIS® trial design and baseline characteristics
Division of Hospital Medicine
Copenhagen University Hospital Rigshospitalet, Denmark
Palliative Care of the Person with Dementia Judy C. Wheeler MSN, MA, GNP-BC Nurse Practitioner, Palliative Care Detroit Receiving Hospital.
Inpatient Palliative Care A hospital service at SOMC where patients can benefit from palliative care consultative services during their hospitalization.
Alcoholic Hepatitis Miriam Nojan PGY-2 April 2016.
Journal Club Leona Isabella von Köckritz.
LIVER HEALTH an integral part of CF gastrointestinal care Zachary M Sellers, MD, PhD Fellow Pediatric Gastroenterology, Hepatology, and Nutrition Stanford.
Community-Acquired Pneumonia Richard G. Wunderink, M.D., and Grant W. Waterer, M.B., B.S., Ph.D. N Engl J Med 2014;370: R3 김선혜 /Prof. 박명재 1.
Risk Factors for Linezolid-Associated Thrombocytopenia in Adult Patients Cristina Gervasoni Ospedale Luigi Sacco, Milano.
CHEST 2013; 144(3): R3 김유진 / Prof. 장나은. Introduction 2  Cardiovascular diseases  common, serious comorbid conditions in patients with COPD cardiac.
EBM Journal Club GS 謝閔傑. 題目 對於治療急性壞死性胰臟炎病患有需要使用抗生 素治療嗎?
Alcoholic Liver Disease Prof.Dr. Khalid A. Al-Khazraji MBCHB, CABM, FRCP, FACP Baghdad medical college
INTERNAL MEDICINE BENJAMIN YIP 4/13/16 Mini Lecture: Hepatorenal Syndrome.
Diagnostic Pathway for Chronic Liver Disease
Liver Disease tutoring Part 1
STOPAH Trial Parth Kothari, MS3
Copenhagen University Hospital Rigshospitalet, Denmark
Copenhagen University Hospital Rigshospitalet, Denmark
Clinical Case Alcoholic Liver disease Prepared By: Tasnim Kullab
HOPE: Heart Outcomes Prevention Evaluation study
Improving the Discharge Process for Hospitalized Patients with Alcohol Use Disorders John Stephens March 22, 2016.
Alcoholic cirrhosis and acute alcoholic fatty liver with cholestasis
Spontaneous Bacterial Peritonitis
Alcoholic foamy degeneration with early alcoholic cirrhosis
Chapter 3 Fatty Liver Diseases 1 Alcoholic steatosis Case 3.1.
Alcoholic hepatitis with diffuse interstitial fibrosis
Grand Rounds: Alcoholic Hepatitis
Copenhagen University Hospital Rigshospitalet, Denmark
Alcoholic liver disease in intensive care
Alcoholic Hepatitis (1)
Internal medicine L-4 Liver cirrhosis & portal hypertension
Acute (Fulminant) Hepatic Failure (FHF)
PRESENTER: Quynh vu, pgy-2
Guideline for the Treatment of Alcohol Use Disorder in the Outpatient Setting with Intramuscular Naltrexone Assess Candidacy for IM Naltrexone Meets DMS-V.
Management of cirrhosis
Management of Alcoholic Hepatitis and Cirrhosis
Presentation transcript:

Alcoholic hepatitis Hospitalist Best Practice J Rush Pierce Jr, MD, MPH Lenny Noronha, MD September 11, 2013

Disclosures Financial: none Affiliations/biases – I drink alcohol – I have a close relative with alcoholism – Evidence should inform our thinking Hospitalist Best Practice: Alcoholic hepatitis09/11/20132

Roadmap for today Describe case Review recommended evaluation & treatment Review the role of MELD and Maddrey’s discriminant calculations Review the literature regarding treatment Discuss discharge criteria Review the role of palliative care Hospitalist Best Practice: Alcoholic hepatitis09/11/20133

Learning Objectives 1.List diagnostic criteria for alcoholic hepatitis. 2.Describe how to use an on-line calculator to predict prognosis and treatment for patients with alcoholic hepatitis. 3.List recommended treatments for alcoholic hepatitis. Hospitalist Best Practice: Alcoholic hepatitis09/11/20134

Case A 53 year-old man with a long history of daily alcohol use presents with one week of jaundice. BP = 95/60 mm Hg, P = 105/minute, and T = 38.0  C. Exam discloses icterus, ascites, and an enlarged, tender liver. Bilirubin = 9 mg/dl, AST = 250 IU/dl, ALT = 115 IU/dl, prothromin time = 22 secs, INR 2.7, creatinine = 0.9 mg/dL, WBC = 15,000/cu mm with 70% neutrophils. How should he be treated? Hospitalist Best Practice: Alcoholic hepatitis09/11/20135

Questions you might have What is his diagnosis? What evaluation should he have? What is his prognosis? How should he be treated? Do we need to call GI? How do we monitor his progress? When can he leave the hospital? 09/11/2013Hospitalist Best Practice: Alcoholic hepatitis6

What is his diagnosis? Regular, heavy alcohol consumption can be associated with a variety of forms of liver disease, including fatty liver, inflammation, hepatic fibrosis and cirrhosis. The term alcoholic hepatitis describes a more severe form of alcohol-related liver disease associated with significant short-term mortality. 09/11/2013Hospitalist Best Practice: Alcoholic hepatitis7

Typical clinical and laboratory features of alcoholic hepatitis FeatureCriteria for alcoholic hepatitis History10 or more years of daily drinking, recent jaundice Examjaundice, enlarged liver Bilirubin> 5 mg/dL AST and ALTboth elevated but both < 400 IU/dL AST/ALT ratio> 2 INRelevated Absolute neutrophil count> 7,700 cells/cu mm 09/11/2013Hospitalist Best Practice: Alcoholic hepatitis8

What evaluation should he have? Confirm the diagnosis Predict prognosis with MELD and Maddrey’s Infectious work-up – ordering blood and urine cultures – chest x-ray – paracentesis to exclude SBP 09/11/2013Hospitalist Best Practice: Alcoholic hepatitis9

Common scoring systems used in management of alcoholic hepatitis Scoring systemData needed to calculate UseInternet calculators MELD – Alcoholic hepatitis Bilirubin, creatinine, INR 90-day prognosishttp:// inic.org/meld/may omodel7.html Maddrey’s discriminant function (mDF) Protime, protime control (13 at UNMH), bilirubin Consideration of anti-inflammatory treatment discriminant- function-for- alcoholic-hepatitis/ Lille ModelDOB, albumin, creatinine, protime at day 0; Bilirubin at days 0 and 7 To judge response to therapy, predict 6-month prognosis after treatment del.com/score.asp 09/11/2013Hospitalist Best Practice: Alcoholic hepatitis10

How should he be treated? TreatmentTherapeutic optionsComments Abstinence from alcoholrehab programs, self-help groups, acamposate, baclofen, disulfiram, naltrexone Usually after discharge NutritionEating, tube feedingsGoal = 35 – 40 kcal/kg per day CorticosteroidsPrednisolone40 mg daily for 28 days followed by a 2 week taper Phosphodiesterase inhibitors Pentoxifylline400 mg TID for 28 days 09/11/2013Hospitalist Best Practice: Alcoholic hepatitis11

Nutrition Enteral nutritional support was shown in a multicenter observational study to be associated with reduced infectious complications and improved one year mortality ACG recommends 35 – 40 kcal/kg per day and protein intake 1.2 – 1.5g/kg per day. In the average 70 kg patient this is 2,450 – 2,800 kcal/day 09/11/2013Hospitalist Best Practice: Alcoholic hepatitis12

Corticosteroids Recommended by ACG for Maddrey’s > 32 Cochrane 2008 review – 15 trials with 721 randomized patients – No overall mortality reduction – Mortality reduced w/Maddrey’s > 32 & HE Another meta-analysis demonstrated a mortality benefit when the largest studies with 221 patients Maddrey’s >32 were analyzed separately 09/11/2013Hospitalist Best Practice: Alcoholic hepatitis13

Corticosteroids Prednisolone is preferred over prednisone because it is the active drug. Concerns include hyperglycemia and increased risk of infection. Contraindications – active infection – gastrointestinal bleeding – acute pancreatitis – renal failure. 09/11/2013Hospitalist Best Practice: Alcoholic hepatitis14

Pentoxifylline Recommended by ACG if corticosteroids are contraindicated A 2008 double-blind, placebo controlled trial (n=101) demonstrated decreased 28-day mortality (24.6% vs. 46% receiving placebo) Cochrane review of all studies concluded that no firm conclusions could be drawn Small randomized trial (n= 68) showed pentoxifylline superior to prednisolone 09/11/2013Hospitalist Best Practice: Alcoholic hepatitis15

Pentoxifylline Can be prescribed to patients who have contraindications to corticosteroid use Dose =400 mg TID for four weeks. Common side effects are nausea & vomiting Cannot be administered by NG tube Should not be used in patients with recent cerebral or retinal hemorrhage. 09/11/2013Hospitalist Best Practice: Alcoholic hepatitis16

DC Med Costs UNM CostUNM Care Co-paySelf Pay Prednisolone 40mg daily #21 (3wks) $1.50$7$10 Pentoxifylline 400mg tid #84 (4 wks) $8$7$100 09/11/2013Hospitalist Best Practice: Alcoholic hepatitis17

Prognosis Case patient MELD = 26 – Confers 43% - 3 month mortality Higher if HE or ascites present – High probability to have cirrhosis if he does survive episode of AAH How should you tell this to patient/family? What considerations follow in this regard? 09/11/2013Hospitalist Best Practice: Alcoholic hepatitis18

Lille Model 09/11/2013Hospitalist Best Practice: Alcoholic hepatitis19 Louvet. Hepatology 2007;45:1348

09/11/2013Hospitalist Best Practice: Alcoholic hepatitis20 Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology Arthur J McCullough and J F Barry O' Connor, Am J Gastr, 1998, 93,

Brief Report on UNMH ‘10-’12 09/11/2013Hospitalist Best Practice: Alcoholic hepatitis21 Total 467 pts 107 Readmissions

UNMH AAH ‘10-’12 cont’d 33 initially adm to MICU 143 spent time in MICU during admission Median age died in hospital – Another 33 reported deaths within 90 days of dc 09/11/2013Hospitalist Best Practice: Alcoholic hepatitis22

UNMH AAH ‘10-’12 Dispo* 09/11/2013Hospitalist Best Practice: Alcoholic hepatitis23 *based on dc order

Great reasons to consult Palliative High mortality condition in young people – Assess understanding of diagnosis/prognosis – Family support – Reinforce your team’s communication (i.e. NG feeds, transplant candidacy, DC) – Support your team – Continuity for pt during long hospitalization Ward team handoff/ICU transfer 09/11/2013Hospitalist Best Practice: Alcoholic hepatitis24

Early Consultation Preferred! All patients c AAH, DF > 32 Please consult as soon as diagnosis suspected – Time to establish rapport 09/11/2013Hospitalist Best Practice: Alcoholic hepatitis25

Palliative Care Consultation Goals of Care Advance Care Planning – Describe dispo options (i.e. SNF, NH, home) – ICU transfer, rehospitalization? – Surrogate decision maker Documentation Guidance to clarify wishes – Code status Patient advocacy Assess spiritual care needs 09/11/2013Hospitalist Best Practice: Alcoholic hepatitis26

Discharge considerations No clinical trials have studied optimal timing of discharge. Expert opinion based on clinical experience recommends that patients be kept in the hospital until they are eating, signs of alcohol withdrawal and encephalopathy are absent, and bilirubin is less than 10 mg/dl Attention to abstinence from EtOH is paramount 09/11/2013Hospitalist Best Practice: Alcoholic hepatitis27

Alcoholic hepatitis - approach 1.Determine that pt fits the clinical picture 2.Admit and cessation of alcohol 3.Order folate, thiamine, MVI, and vitamin K. 4.Add a note about potential withdrawal to hand-off report. 5.Order an infectious work-up (blood and urine cultures, CXR, and paracentesis). 09/11/2013Hospitalist Best Practice: Alcoholic hepatitis28

Alcoholic hepatitis - approach 6.Dietary consult for calorie counts, importance of > 2,500 cals/day. 7.Consider tube feedings if not meeting goal 8.Determine Maddrey’s and MELD scores 9. Order prednisolone 40 mg daily; if actively bleeding or infected, Trental 400 mg TID 10. Determine Lille score treatment day Discuss code status and end-of life issues 12. Consider GI consult 09/11/2013Hospitalist Best Practice: Alcoholic hepatitis29

Alcoholic hepatitis – areas of possible consensus Use of NG feedings for nutrition When to call GI When to call palliative care Evaluation of afebrile leukocytosis Discharge criteria 09/11/2013Hospitalist Best Practice: Alcoholic hepatitis30